# A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.

> **NCT03505190** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 41 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** RO7062931
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03505190
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2019-07-05
- **Final completion:** 2019-07-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03505190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03505190, "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03505190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*